These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 25560394)

  • 1. Fluvoxamine by itself has potential to directly induce long QT syndrome at supra-therapeutic concentrations.
    Yamazaki-Hashimoto Y; Nakamura Y; Ohara H; Cao X; Kitahara K; Izumi-Nakaseko H; Ando K; Yamazaki H; Ikeda T; Yamazaki J; Sugiyama A
    J Toxicol Sci; 2015 Feb; 40(1):33-42. PubMed ID: 25560394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo canine model comparison of cardiovascular effects of antidepressants milnacipran and imipramine.
    Mitsumori Y; Nakamura Y; Hoshiai K; Nagayama Y; Adachi-Akahane S; Koizumi S; Matsumoto M; Sugiyama A
    Cardiovasc Toxicol; 2010 Dec; 10(4):275-82. PubMed ID: 20680703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of Safety Margin of Lithium Carbonate Against Cardiovascular Adverse Events Assessed in the Halothane-Anesthetized Dogs.
    Goto A; Nakamura Y; Lubna NJ; Chiba K; Hagiwara-Nagasawa M; Izumi-Nakaseko H; Ando K; Naito AT; Sugiyama A
    Cardiovasc Toxicol; 2018 Dec; 18(6):530-536. PubMed ID: 29845450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electropharmacological Characterization of Aciclovir in the Halothane-Anesthetized Dogs: A Proposal of Evaluation Method for Cardiovascular Safety Pharmacology of Anti-virus Drugs.
    Kondo Y; Hagiwara-Nagasawa M; Kambayashi R; Goto A; Chiba K; Nunoi Y; Izumi-Nakaseko H; Matsumoto A; Sugiyama A
    Cardiovasc Toxicol; 2020 Aug; 20(4):419-426. PubMed ID: 32193875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electropharmacological effects of amantadine on cardiovascular system assessed with J-Tpeak and Tpeak-Tend analysis in the halothane-anesthetized beagle dogs.
    Cao X; Nakamura Y; Wada T; Izumi-Nakaseko H; Ando K; Sugiyama A
    J Toxicol Sci; 2016; 41(3):439-47. PubMed ID: 27193735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of microminipig as a laboratory animal for safety pharmacology study by analyzing fluvoxamine-induced cardiovascular and dermatological adverse reactions.
    Tanikawa Y; Hagiwara-Nagasawa M; Kambayashi R; Goto A; Chiba K; Kitta K; Hoshiai K; Izumi-Nakaseko H; Naito AT; Sugiyama A
    Cardiovasc Toxicol; 2019 Oct; 19(5):412-421. PubMed ID: 30734885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amitriptyline May Have Possibility to Induce Brugada Syndrome Rather than Long QT Syndrome.
    Lubna NJ; Wada T; Nakamura Y; Chiba K; Cao X; Izumi-Nakaseko H; Ando K; Naito AT; Satoh Y; Sugiyama A
    Cardiovasc Toxicol; 2018 Feb; 18(1):91-98. PubMed ID: 28616803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Azithromycin Can Prolong QT Interval and Suppress Ventricular Contraction, but Will Not Induce Torsade de Pointes.
    Ohara H; Nakamura Y; Watanabe Y; Cao X; Yamazaki Y; Izumi-Nakaseko H; Ando K; Yamazaki H; Yamazaki J; Ikeda T; Sugiyama A
    Cardiovasc Toxicol; 2015 Jul; 15(3):232-40. PubMed ID: 25367413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo Analysis of the Anti-atrial Fibrillatory, Proarrhythmic and Cardiodepressive Profiles of Dronedarone as a Guide for Safety Pharmacological Evaluation of Antiarrhythmic Drugs.
    Motokawa Y; Nakamura Y; Hagiwara-Nagasawa M; Goto A; Chiba K; Lubna NJ; Izumi-Nakaseko H; Ando K; Naito AT; Yamazaki H; Sugiyama A
    Cardiovasc Toxicol; 2018 Jun; 18(3):242-251. PubMed ID: 29139031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of electropharmacological effects between terfenadine and its active derivative fexofenadine using a cross-over study in halothane-anesthetized dogs to analyze variability of pharmacodynamic and pharmacokinetic profiles of terfenadine and torsadogenic risk of fexofenadine.
    Ando K; Nakamura Y; Hagiwara-Nagasawa M; Harada H; Miyamoto H; Inamura N; Takagi K; Goto A; Chiba K; Lubna NJ; Izumi-Nakaseko H; Naito AT; Sugiyama A
    J Toxicol Sci; 2018; 43(3):183-192. PubMed ID: 29540652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study of QT prolongation with serotonin reuptake inhibitors.
    Ojero-Senard A; Benevent J; Bondon-Guitton E; Durrieu G; Chebane L; Araujo M; Montastruc F; Montastruc JL
    Psychopharmacology (Berl); 2017 Oct; 234(20):3075-3081. PubMed ID: 28770276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Observation of QTc prolongation in an adolescent girl during fluvoxamine pharmacotherapy.
    Brzozowska A; Werner B
    J Child Adolesc Psychopharmacol; 2009 Oct; 19(5):591-2. PubMed ID: 19877986
    [No Abstract]   [Full Text] [Related]  

  • 13. Electropharmacological characterization of microminipigs as a laboratory animal using anti-influenza virus drug oseltamivir.
    Lubna NJ; Nakamura Y; Hagiwara-Nagasawa M; Goto A; Chiba K; Kitta K; Izumi-Nakaseko H; Ando K; Naito AT; Akie Y; Sugiyama A
    J Toxicol Sci; 2018; 43(8):507-512. PubMed ID: 30078836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of proarrhythmic potential of an atypical antipsychotic drug paliperidone in the halothane-anesthetized dogs.
    Chiba K; Wada T; Nakamura Y; Cao X; Hagiwara-Nagasawa M; Izumi-Nakaseko H; Ando K; Tanaka K; Naito AT; Sugiyama A
    J Pharmacol Sci; 2017 Aug; 134(4):239-246. PubMed ID: 28844424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical impact of fluvoxamine-mediated long QTU syndrome.
    Nia AM; Dahlem KM; Gassanov N; Hungerbühler H; Fuhr U; Er F
    Eur J Clin Pharmacol; 2012 Jan; 68(1):109-11. PubMed ID: 21713517
    [No Abstract]   [Full Text] [Related]  

  • 16. Sensitivity and Reliability of Halothane-anaesthetized Microminipigs to Assess Risk of Drug-induced Long QT Syndrome.
    Cao X; Wada T; Nakamura Y; Matsukura S; Izumi-Nakaseko H; Ando K; Naito AT; Sugiyama A
    Basic Clin Pharmacol Toxicol; 2017 Dec; 121(6):465-470. PubMed ID: 28654209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous Administration of Apomorphine Does NOT Induce Long QT Syndrome: Experimental Evidence from In Vivo Canine Models.
    Watanabe Y; Nakamura Y; Cao X; Ohara H; Yamazaki Y; Murayama N; Sugiyama Y; Izumi-Nakaseko H; Ando K; Yamazaki H; Sugiyama A
    Basic Clin Pharmacol Toxicol; 2015 Jun; 116(6):468-75. PubMed ID: 25370785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiohemodynamic and electrophysiological effects of a selective EP4 receptor agonist ONO--AE1--329 in the halothane-anesthetized dogs.
    Nomura H; Nakamura Y; Cao X; Honda A; Katagi J; Ohara H; Izumi-Nakaseko H; Satoh Y; Ando K; Sugiyama A
    Eur J Pharmacol; 2015 Aug; 761():217-25. PubMed ID: 26073024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How the Deuteration of Dronedarone Can Modify Its Cardiovascular Profile: In Vivo Characterization of Electropharmacological Effects of Poyendarone, a Deuterated Analogue of Dronedarone.
    Kambayashi R; Hagiwara-Nagasawa M; Kondo Y; Yeo ZJ; Goto A; Chiba K; Nunoi Y; Izumi-Nakaseko H; Leow JWH; Venkatesan G; Matsumoto A; Chan ECY; Sugiyama A
    Cardiovasc Toxicol; 2020 Aug; 20(4):339-350. PubMed ID: 31898152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo characterization of anti-atrial fibrillatory potential and pharmacological safety profile of I
    Nunoi Y; Kambayashi R; Goto A; Hagiwara-Nagasawa M; Chiba K; Izumi-Nakaseko H; Kawai S; Takei Y; Matsumoto A; Watanabe Y; Sugiyama A
    Heart Vessels; 2021 Jul; 36(7):1088-1097. PubMed ID: 33763729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.